Bi, Jianbin
Zhang, Jia
Ke, Mengyun
Wang, Tao
Wang, Mengzhou
Liu, Wuming
Du, Zhaoqing
Ren, Yifan
Zhang, Shuqun
Wu, Zheng
Lv, Yi http://orcid.org/0000-0003-3636-6664
Wu, Rongqian http://orcid.org/0000-0003-0993-4531
Article History
Received: 16 July 2022
Revised: 15 September 2022
Accepted: 16 September 2022
First Online: 27 September 2022
Competing interests
: RW, JZ, and JB are the inventor of a patent (ZL 202010490337.0, China) entitled “The application of HSF2BP in ischemia-reperfusion- or drug-induced liver injury”. This patent covers the fundamental concept of using HSF2BP as a therapeutic target for ischemia-reperfusion- or drug-induced liver injury.